BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2719011)

  • 1. Poor outcome from peritoneovenous shunts for refractory ascites.
    Scholz DG; Nagorney DM; Lindor KD
    Am J Gastroenterol; 1989 May; 84(5):540-3. PubMed ID: 2719011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneovenous shunts--devices of last resort.
    Shepherd KE; Miller BJ
    Can J Surg; 1988 Nov; 31(6):444-7. PubMed ID: 3179855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneovenous shunts: predictive factors of early treatment failure.
    Gleysteen JJ; Klamer TW
    Am J Gastroenterol; 1984 Aug; 79(8):654-8. PubMed ID: 6465113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.
    Smith RE; Nostrant TT; Eckhauser FE; Wilson JP; Knol JA; Strodel WE
    Am J Gastroenterol; 1984 Aug; 79(8):659-62. PubMed ID: 6465114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
    Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
    Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peritoneovenous shunt: expectations and reality.
    Moskovitz M
    Am J Gastroenterol; 1990 Aug; 85(8):917-29. PubMed ID: 2197858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneovenous shunt insertion for intractable ascites: a district general hospital experience.
    Hussain FF; Meer ZF; Lopez AJ
    Cardiovasc Intervent Radiol; 2004; 27(4):325-8. PubMed ID: 15346206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneovenous shunting for cirrhotic versus malignant ascites.
    Kostroff KM; Ross DW; Davis JM
    Surg Gynecol Obstet; 1985 Sep; 161(3):204-8. PubMed ID: 2412302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease.
    Vadeyar HJ; Doran JD; Charnley R; Ryder SD
    Br J Surg; 1999 Jul; 86(7):882-5. PubMed ID: 10417558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneovenous shunting for intractable ascites.
    Gullstrand P; Alwmark A; Börjesson B; Joelsson B; Bengmark S
    Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
    Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
    Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of LeVeen shunting in refractory ascites--a view from the other side.
    Grischkan DM; Cooperman AM; Hermann RE; Carey WD; Ferguson DR; Cook SA
    Surgery; 1981 Mar; 89(3):304-8. PubMed ID: 7466618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneovenous shunts in patients with intractable ascites: palliation at what price?
    Zervos EE; McCormick J; Goode SE; Rosemurgy AS
    Am Surg; 1997 Feb; 63(2):157-62. PubMed ID: 9012430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Palliative treatment of carcinomatous ascites with peritoneovenous shunt].
    Castellví Suaña JM; Baliellas Comellas C; Fabregat Prous J; Torras Torra J; Guardiola Capón J; Sánchez Gili M
    Rev Esp Enferm Dig; 1992 Nov; 82(5):331-3. PubMed ID: 1485985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term effectiveness, morbidity, and mortality of peritoneovenous shunt inserted to treat massive refractory ascites of nephrogenic origin analysis of 14 cases.
    Holm A; Rutsky EA; Aldrete JS
    Am Surg; 1989 Nov; 55(11):645-52. PubMed ID: 2479308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of ascites with Le Veen shunt in patients with alcoholic liver disease].
    D'Albuquerque LA; de Oliveira e Silva A; Genzini T; de Miranda MP; dos Santos TE; Roldan-Molina F; Gama-Rodrigues J
    Arq Gastroenterol; 1990; 27(3):126-31. PubMed ID: 2099140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [12-year experience with continuous peritoneovenous shunt in the treatment of therapy-resistant ascites and hepatorenal failure: benefits and pitfalls].
    Kreuzer W
    Wien Klin Wochenschr; 1989 Jan; 101(2):87-91. PubMed ID: 2916345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.